Skip to main content
TipRanks
Go Ultimate75% OFF

Christoph Westphal Insider Profile

11 Followers

Christoph Westphal, Ten Percent Owner at TScan Therapeutics, holds 2.32M shares in TScan Therapeutics (Ticker: TCRX), holds 3.94M shares in Decoy Therapeutics (Ticker: DCOY), holds 2.17M shares in Verastem (Ticker: VSTM).

Christoph Westphal's Trading History

TCRX
TScan Therapeutics
Jul 22, 2021Ten Percent OwnerUninformative Buy―$335.74K
DCOY
Decoy Therapeutics
Oct 18, 2018Ten Percent OwnerInformative Sell2.92M$3.55M
VSTM
Verastem
Jul 01, 2015EC, DirectorUninformative Sell18.17K$16.67M
TPST
Tempest Therapeutics
Mar 11, 2014Director, Ten Percent OwnerInformative Buy1.00M$1.54M
MNTA
Momenta Pharma
―――$0.00
ALNY
Alnylam Pharma
―Director, Ten Percent Owner―$384.94M

You May Also Like

Christoph Westphal insider profile FAQ

What is the percentage of profitable transactions made by Christoph Westphal?
The percentage of profitable transactions made by Christoph Westphal is 10%.
What is the average return per transaction made by Christoph Westphal?
The average return per transaction made by Christoph Westphal is -45.60%.
What stocks does Christoph Westphal hold?
Christoph Westphal holds: TCRX, DCOY, VSTM, ALNY, TPST, MNTA stocks.
What was Christoph Westphal's most profitable transaction?
Christoph Westphal’s most profitable transaction was an Informative Buy of TPST stock on March 11, 2014. The return on the trade was 347.50%.
What is Christoph Westphal's role in TScan Therapeutics?
Christoph Westphal's role in TScan Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.